Goldman A - Search Results

1

A call to arms: Unifying the fight against resistance.

Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA. Kaushansky A, et al. Among authors: goldman a. Sci Signal. 2018 Oct 23;11(553):eaav0442. doi: 10.1126/scisignal.aav0442. Sci Signal. 2018. PMID: 30352947 Free PMC article.

2

Tailoring combinatorial cancer therapies to target the origins of adaptive resistance.

Goldman A. Goldman A. Mol Cell Oncol. 2015 Apr 14;3(1):e1030534. doi: 10.1080/23723556.2015.1030534. eCollection 2016 Jan. Mol Cell Oncol. 2015. PMID: 27308546 Free PMC article.

3

Perspective on nanochannels as cellular mediators in different disease conditions.

Jash E, Prasad P, Kumar N, Sharma T, Goldman A, Sehrawat S. Jash E, et al. Among authors: goldman a. Cell Commun Signal. 2018 Nov 8;16(1):76. doi: 10.1186/s12964-018-0281-7. Cell Commun Signal. 2018. PMID: 30409198 Free PMC article. Review.

4

Drug-induced resistance: nipping it in the 'budding'.

Goldman A. Goldman A. Oncotarget. 2018 Nov 13;9(89):35873-35874. doi: 10.18632/oncotarget.26328. eCollection 2018 Nov 13. Oncotarget. 2018. PMID: 30543207 Free PMC article. No abstract available.

5

Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model.

Moghimi N, Hosseini SA, Dalan AB, Mohammadrezaei D, Goldman A, Kohandel M. Moghimi N, et al. Among authors: goldman a. Sci Rep. 2023 Aug 22;13(1):13648. doi: 10.1038/s41598-023-40680-x. Sci Rep. 2023. PMID: 37607994 Free PMC article.

6

Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects.

Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Farahani MV, Hushmandi K, Zarrabi A, Goldman A, Ashrafizadeh M, Orive G. Mirzaei S, et al. Among authors: goldman a. Drug Discov Today. 2022 Feb;27(2):436-455. doi: 10.1016/j.drudis.2021.09.020. Epub 2021 Oct 6. Drug Discov Today. 2022. PMID: 34624510 Free article. Review.

7

Perspectives on the role of brain cellular players in cancer-associated brain metastasis: translational approach to understand molecular mechanism of tumor progression.

Raza M, Prasad P, Gupta P, Kumar N, Sharma T, Rana M, Goldman A, Sehrawat S. Raza M, et al. Among authors: goldman a. Cancer Metastasis Rev. 2018 Dec;37(4):791-804. doi: 10.1007/s10555-018-9766-5. Cancer Metastasis Rev. 2018. PMID: 30284650 Review.

8

cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer.

Kumar N, Prasad P, Jash E, Jayasundar S, Singh I, Alam N, Murmu N, Somashekhar SP, Goldman A, Sehrawat S. Kumar N, et al. Among authors: goldman a. Carcinogenesis. 2018 Oct 8;39(10):1245-1253. doi: 10.1093/carcin/bgy090. Carcinogenesis. 2018. PMID: 29982410 Free PMC article.

9

Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment.

Kumar N, Prasad P, Jash E, Saini M, Husain A, Goldman A, Sehrawat S. Kumar N, et al. Among authors: goldman a. Mol Cell Biochem. 2018 Oct;447(1-2):77-92. doi: 10.1007/s11010-018-3294-z. Epub 2018 Feb 7. Mol Cell Biochem. 2018. PMID: 29417338 Review.

10

Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.

Shouval R, Goldman A, Flynn JR, El-Moghraby A, Rehman M, Devlin SM, Corona M, Landego I, Lin RJ, Scordo M, Raj SS, Giralt SA, Palomba ML, Dahi PB, Walji M, Salles G, Nath K, Geyer MB, Park JH, Fein JA, Kosmidou I, Shah GL, Liu JE, Perales MA, Mahmood SS. Shouval R, et al. Among authors: goldman a. Br J Haematol. 2024 May 12. doi: 10.1111/bjh.19497. Online ahead of print. Br J Haematol. 2024. PMID: 38735683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,027 results

Search Page